Document is current
Any future updates will be listed below
-
Authors
Messelink, Marianne A. https://orcid.org/0000-0002-6291-3134
Roodenrijs, Nadia M. T.
van Es, Bram
Hulsbergen-Veelken, Cornelia A. R.
Jong, Sebastiaan
Overmars, L. Malin
Reteig, Leon C.
Tan, Sander C.
Tauber, Tjebbe
van Laar, Jacob M.
Welsing, Paco M. J.
Haitjema, Saskia
-
Funding
Funding for this research was provided by:
Galapagos NL
- License Information
-
More Information
Article History
Received: 29 March 2021
Accepted: 21 June 2021
First Online: 8 July 2021
Declarations
:
: The medical ethics committee of UMC Utrecht approved of the study under number 20/724 and waived the need for informed consent.
: Not applicable.
: MAM, NMTR, CH, and PMJW declare to have no competing interests. BvE, SJ, and TT are stockholders of MedxAI. LMO, LCR, and SCT are freelancers for MedxAI. JMvL reports personal fees from Arxx Tx, Gesyntha, Magenta, Sanofi Genzyme, Leadiant, Boehringer-Ingelheim, and Galapagos; grants and personal fees from Roche; grants from Astra Zeneca, MSD, and Thermo Fisher; all outside the submitted work. SH is supported by a fellowship of Abbott Diagnostics.
